Hydroxychloroquine is metabolized primarily in the liver, with a small proportion excreted unchanged in the urine.
plaquenil Hepatic impairment can affect the drug's metabolism and clearance, potentially leading to increased blood levels and a higher risk of adverse effects. Patients with liver disease should be monitored closely during hydroxychloroquine therapy, with dosage adjustments made as necessary to avoid toxicity.